Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 2 EP applications Nikolai Graf Keyserlingk has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after May 5, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP16186474

NOVEL RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH DECREASED DURATION OF EFFECT

IPC classification:
A61K 38/16, A61Q 19/00, C07K 14/33, C12N 9/52
Applicant:
Merz Pharma GmbH & Co. KGaA
Agent:
Nikolai Graf Keyserlingk, Merz Pharma GmbH & Co. KGaA
Status:
The application has been published
EP16194560

NOVEL RECOMBINANT BOTULINUM NEUROTOXINS WITH ACCELERATED ONSET OF EFFECT

IPC classification:
A61K 8/64, A61K 38/16, C07K 14/33, C12N 9/52
Applicant:
Merz Pharma GmbH & Co. KGaA
Agent:
Nikolai Graf Keyserlingk, Merz Pharma GmbH & Co. KGaA
Status:
The application has been published

Please Sign in to use this feature